510(k) Report

510(k) · Cleared

Cleared

DRI OCT Triton

K173119510(k) TraditionalCleared Jan 19, 2018112-day reviewClass II21 CFR 886.1570

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Topcon Corporation · OBO Tomography, Optical Coherence

Cleared on Jan 19, 2018 as substantially equivalent to K161509 (Topcon Corporation, 2016) and 2 other predicates after a 112-day review. Its family tree reaches back 9 generations to 2002.

Decided
Jan 19, 2018
Review
112 days
Class
Class II
Product code
OBO
Recalls
None
Predicates
3

Its longest line of descent runs back 9 generations to K012727 (2002). 28 ancestors in all, the oldest K946058 (1995). No later device cites it as a predicate yet.

  1. Root · 9 generations backK012727 Humphrey OCT3Carl Zeiss Ophthalmic Systems, Inc. · 2002
  2. 5 generations between
  3. 3 generations backK121739 Ivue with Normative DatabaseOptovue, Inc. · 2013 · Recalled
  4. 2 generations backK161509 3D OCT-1 MaestroTopcon Corporation · 2016
  5. 1 generation backK170164 3D OCT-1 MaestroTopcon Corporation · 2017
  6. This deviceK173119 DRI OCT TritonTopcon Corporation · 2018
Show all 9 generations
  1. Root · 9 generations backK012727 Humphrey OCT3Carl Zeiss Ophthalmic Systems, Inc. · 2002
  2. 8 generations backK030433 Stratusoct with RNFL Normative DatabaseCarl Zeiss Meditec, Inc. · 2003 · Recalled
  3. 7 generations backK033123 Stratusoct with RNFL & Macula Normative DatabaseCarl Zeiss Meditec, Inc. · 2004 · Recalled
  4. 6 generations backK063343 Bioptigen Spectral Domain Ophthalmic Imaging SystemBioptigen, Inc. · 2006
  5. 5 generations backK071250 CA, Model: CamOptovue, Inc. · 2007
  6. 4 generations backK091404 Ivue, Model 100Optovue, Inc. · 2010 · Recalled
  7. 3 generations backK121739 Ivue with Normative DatabaseOptovue, Inc. · 2013 · Recalled
  8. 2 generations backK161509 3D OCT-1 MaestroTopcon Corporation · 2016
  9. 1 generation backK170164 3D OCT-1 MaestroTopcon Corporation · 2017
  10. This deviceK173119 DRI OCT TritonTopcon Corporation · 2018
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−9K012727Humphrey OCT3Carl Zeiss Ophthalmic Systems, Inc.2002—
−8K030433Stratusoct with RNFL Normative DatabaseCarl Zeiss Meditec, Inc.20031
−7K033123Stratusoct with RNFL & Macula Normative DatabaseCarl Zeiss Meditec, Inc.20041
−6K063343Bioptigen Spectral Domain Ophthalmic Imaging SystemBioptigen, Inc.2006—
−5K071250CA, Model: CamOptovue, Inc.2007—
−4K091404Ivue, Model 100Optovue, Inc.20102
−3K121739Ivue with Normative DatabaseOptovue, Inc.20133
−2K1615093D OCT-1 MaestroTopcon Corporation2016—
−1K1701643D OCT-1 MaestroTopcon Corporation2017—
0 (this device)K173119DRI OCT TritonTopcon Corporation2018—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199530
199810
200210
200310
200420
200520
200610
200710
200810
200910
201030
201320
FIG. 1 — Lineage of K173119, 2002–2018Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in OBO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new OBO device

  1. #1 K250868 SPECTRALIS HRA+OCT and variantsscore 16.2 · 14 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K1615093D OCT-1 Maestro
Summary page 4
…pe Regulation: Class II, 21 C.F.R. § 886.1570 Product Code(s): OBO, HKI Predicate Device(s): Primary Predicate: Topcon 3D OCT-1 Maestro (#K161509, #K170164) Secondary Predicate: Topcon TRC-50DX Retinal Camera (#K123101) Indications for Use: The Topcon D…
Topcon Corporation2016—
*K1701643D OCT-1 Maestro
Summary page 4
…tion: Class II, 21 C.F.R. § 886.1570 Product Code(s): OBO, HKI Predicate Device(s): Primary Predicate: Topcon 3D OCT-1 Maestro (#K161509, #K170164) Secondary Predicate: Topcon TRC-50DX Retinal Camera (#K123101) Indications for Use: The Topcon DRI OCT Tri…
Topcon Corporation2017—
*K123101TRC-50DX Retinal Camera
Summary page 4
…OBO, HKI Predicate Device(s): Primary Predicate: Topcon 3D OCT-1 Maestro (#K161509, #K170164) Secondary Predicate: Topcon TRC-50DX Retinal Camera (#K123101) Indications for Use: The Topcon DRI OCT Triton is a non-contact, high resolution tomographic and biomicroscopic…
Topcon Medical Systems, Inc.2013—

Also cleared against K161509: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 16 years and passes through 5 companies; a new generation was cleared every 1.2 years on median.
  • 5 of the 28 ancestors have a recall of any class.
  • 2 other devices also cite its predicate K161509.

How does its category compare?

All OBO devices

OBO Tomography, Optical Coherence: FDA decisions, review times, recalls and adverse event reports over 20 years. 2018, this device’s year, is highlighted.

FDA decisions per year · OBO

3in 2025

2007: 22008: 22009: 42010: 22011: 22012: 32013: 22014: 32015: 12016: 42017: 42018: 62019: 52020: 22021: 12022: 22023: 72024: 82025: 32026 (partial year): 2
2007high 8 (2024) · low 1 (2015)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OBO

125in 2025

2009: 151 days median2012: 269 days median2014: 152 days median2016: 125 days median2017: 118 days median2018: 87 days median2019: 249 days median2023: 262 days median2024: 157 days median2025: 125 days median
2007high 269 (2012) · low 87 (2018)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · OBO

1in 2022

2010: 12011: 22012: 22018: 12021: 12022: 12026 (partial year): 1
2007high 2 (2011) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · OBO

4in 2025

2013: 22016: 12018: 12021: 12023: 32024: 32025: 4
2007high 4 (2025) · low 0 (2007)2025

MAUDE reports naming product code OBO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—00
20082—00
2009415100
20102—10
20112—20
2012326920
20132—02
2014315200
20151—00
2016412501
2017411800
201868711
2019524900
20202—00
20211—11
20222—10
2023726203
2024815703
2025312504
20262—1—

What is it indicated for?

The Topcon DRI OCT Triton is a non-contact, high resolution tomographic and biomicroscopic imaging device that incorporates a digital camera for photographing, displaying and storing the data of the retina and surrounding parts of the eye to be examined under Mydriatic and non-Mydriatic conditions. The DRI OCT Triton is indicated for in vivo viewing, axial cross sectional, and three-dimensional imaging and measurement of posterior ocular structures…

Read the full statement (151 words)

The Topcon DRI OCT Triton is a non-contact, high resolution tomographic and biomicroscopic imaging device that incorporates a digital camera for photographing, displaying and storing the data of the retina and surrounding parts of the eye to be examined under Mydriatic and non-Mydriatic conditions.

The DRI OCT Triton is indicated for in vivo viewing, axial cross sectional, and three-dimensional imaging and measurement of posterior ocular structures, including retina, retinal nerve fiber layer, macula and optic disc as well as imaging of anterior ocular structures.

It also includes a Reference Database for posterior ocular measurements which provide for the quantitative comparison of retinal nerve fiber layer, optic nerve head, and the macula in the human retina to a database of known normal subjects. The DRI OCT Triton is indicated for use as a diagnostic device to aid in the diagnosis, documentation and management of ocular health and diseases in the adult population.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K173119: DRI OCT Triton.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K173119

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026